Healthcare Services Group, Inc. (HCSG)
NASDAQ: HCSG · Real-Time Price · USD
13.79
+0.12 (0.88%)
At close: Apr 28, 2025, 4:00 PM
13.79
0.00 (0.00%)
After-hours: Apr 28, 2025, 5:35 PM EDT
Healthcare Services Group Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Healthcare Services Group stock have an average target of 14.8, with a low estimate of 13 and a high estimate of 17. The average target predicts an increase of 7.32% from the current stock price of 13.79.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Healthcare Services Group stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Macquarie | Macquarie | Hold Maintains $15 | Hold | Maintains | $15 | +8.77% | Apr 28, 2025 |
| Baird | Baird | Hold Maintains $12 → $13 | Hold | Maintains | $12 → $13 | -5.73% | Apr 24, 2025 |
| UBS | UBS | Hold → Strong Buy Upgrades $12 → $15 | Hold → Strong Buy | Upgrades | $12 → $15 | +8.77% | Apr 24, 2025 |
| Benchmark | Benchmark | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +23.28% | Dec 19, 2024 |
| Macquarie | Macquarie | Hold Initiates $13 | Hold | Initiates | $13 | -5.73% | Dec 16, 2024 |
Financial Forecast
Revenue This Year
1.84B
from 1.72B
Increased by 6.95%
Revenue Next Year
1.91B
from 1.84B
Increased by 4.09%
EPS This Year
0.77
from 0.53
Increased by 45.30%
EPS Next Year
0.85
from 0.77
Increased by 10.26%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.9B | 2.0B | 2.0B |
| Avg | 1.8B | 1.9B | 2.0B |
| Low | 1.8B | 1.8B | 1.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 10.4% | 8.0% | 6.1% |
| Avg | 7.0% | 4.1% | 3.1% |
| Low | 2.2% | -0.4% | -0.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.85 | 0.96 | 1.01 |
| Avg | 0.77 | 0.85 | 0.98 |
| Low | 0.63 | 0.69 | 0.94 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 60.5% | 24.1% | 18.7% |
| Avg | 45.3% | 10.3% | 15.3% |
| Low | 18.3% | -10.9% | 10.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.